Talisay Jr, Eusebio F.

HRN: 29-34-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/23/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/23/2026
07/23/2026
IV
4.5g
LD
CAP MR, Cellulitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  PneumoniaSkin & Soft Tissue    Compliance to guidelines: